• Tue news: Merck's Keytruda stages comeback in head and neck cancer. GSK, Pfizer RSV vaccine sales fall. Astellas gene therapy bet. Extreme weather —>drug shortages. J&J discontinues bladder cancer drug. See more on our front page

MannKind

Anonymous board for MannKind
Replies
2
Views
264
Replies
22
Views
2K
anonymous
Replies
8
Views
506
anonymous
Replies
10
Views
5K
anonymous
Replies
5
Views
315
anonymous
Replies
11
Views
2K
anonymous
Replies
7
Views
983
anonymous
Replies
47
Views
7K
anonymous
Replies
4
Views
465
anonymous
Replies
1
Views
200
anonymous
Replies
6
Views
1K
anonymous
Replies
0
Views
177
anonymous
Replies
1
Views
1K
anonymous
Replies
3
Views
2K
anonymous
Replies
20
Views
4K
anonymous
Hub
Replies
4
Views
822
anonymous
Replies
10
Views
970
anonymous
Replies
11
Views
3K
anonymous
Replies
4
Views
1K
anonymous